Investor Relations

At Adhera, we pride ourselves on innovation, only in a manner where we push the limits of de-risking drug development in pursuit of our bold goal to change the future of medicine for millions of patients in need.

To achieve our goals, we have assembled a unique portfolio of compounds at various levels of development.

We aim for compounds that demonstrate rich safety, tolerability, and efficacy profiles established through clinical trials involving hundreds of patients or decades of marketing in real-world cases. We don’t look at these drugs through the same lens as predecessors, though. We see new uses for them in areas of great unmet medical need, such as Type 1 Diabetes, Parkinson’s Disease, and Cancer. With our team steeped in all areas of drug development experience and access to some of the world’s brightest scientific minds, we intend to develop best-in-class therapies that can re-imagine the standard of care in different indications, simultaneously benefiting mankind and building shareholder value. We value the loyalty of our investors and welcome those new to Adhera to the next generation of patient care for hard-to-treat diseases.

Stock & Press Releases

Adhera trades at OTC Markets under the symbol ATRX

Corporate Presentation

All the information you need to get started with Adhera

Download Now
In-Depth Information

All the information you need to get started with Adhera

Market Statistics and Facts

All the information you need to get started with Adhera

Drug Development Pipeline

All the information you need to get started with Adhera